A new study published in Nature Genetics, titled “A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification,” investigates how tumor microenvironmental features influence risk stratification and computational tumor classification in meningioma.
The work shows that meningioma risk is better represented as a continuum shaped by the tumor microenvironment, particularly immune cell composition and activation states, rather than by strictly discrete molecular subtypes. By integrating molecular profiling with computational analyses, the study demonstrates that microenvironmental signals substantially contribute to tumor aggressiveness and help explain variability in machine learning-based classification results.
Importantly, the findings suggest that microenvironment-related features, including those accessible through routine histopathological assessment, may complement molecular assays and improve clinically relevant risk prediction.
Researchers from the institute contributed to the computational and interdisciplinary aspects of the study, highlighting the importance of context-aware and biologically informed AI methods in biomedical research.